Overview

A Study of PLX2853 in Advanced Malignancies.

Status:
Recruiting

Trial end date:
2022-06-01

Target enrollment:

Participant gender:

Summary

The purpose of this research study is to evaluate safety, pharmacokinetics, pharmacodynamics and preliminary efficacy of the investigational drug PLX2853 in subjects with advanced malignancies.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Plexxikon